A Trial of GFH018 and Toripalimab in Combination With Concurrent Chemoradiotherapy in Stage III NSCLC Chemoradiotherapy in Stage III NSCLC

Clinical trial NCT05386888 · COMPLETED

Trial details

NCT number: NCT05386888
Sponsor: Genfleet Therapeutics (Shanghai) Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

NSCLC, Stage III

Start date: 2022-09-09
Primary completion: 2023-12-31
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.